← Open Payments lookup

PAUL LARSEN: Open Payments

NPI 1720189749 · CHEWELAH, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$187 in 10 payments from 8 companies in 2025. Trend: 2023 $72 · 2024 $90 · 2025 $187

Food & beverage: $187
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.2$46
ABBVIE INC.2$32
Dexcom, Inc.1$24
Novo Nordisk Inc1$24
VERTEX PHARMACEUTICALS INCORPORATED1$20
PFIZER INC.1$17
AstraZeneca Pharmaceuticals LP1$17
Phathom Pharmaceuticals, Inc.1$7

Products named: JARDIANCE, Dexcom G6 Transmitter, Ozempic, JOURNAVX, UBRELVY, NURTEC ODT, FARXIGA, QULIPTA.

Industry payments across WA — which companies pay providers there.